Author:
Kumar Kunal,Kumar Deepak,Srinivas Abhishek
Publisher
Jaypee Brothers Medical Publishing
Reference13 articles.
1. 1. WHO, 2010. The Global Prevalence of Hepatitis A Virus Infection and Susceptibility: A Systematic Review. Available from http://apps.who.int/iris/bitstream/10665/70180/1/WHO_IVB_10.01_eng.pdf. [Last accessed May, 2018].
2. 2. Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis 2015;28(5):488–496. DOI: 10.1097/QCO.0000000000000188
3. 3. Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses 2021;13(10):1900. DOI: 10.3390/v13101900
4. 4. Raymond S, Koff MD. Handbook of Liver Disease, 3rd edition. Philadelphia: Elsevier Health Sciences; 2012.
5. 5. Pullukçu H, Kahraman H, Yamazhan T, et al. Use of steroids for prolonged cholestasis secondary to acute hepatitis A infection. J Microbiol Infect Dis 2014;4(4):162–164. DOI: 10.5799/ahinjs.02.2014.04.0161